Yuri Maricich

Insider Reports History

Entity
Individual
Location
C/O Pear Therapeutics, Inc., 200 State Street, 13 Th Floor, Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yuri Maricich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Chief Medical Officer Restricted Stock Units 1.33M Feb 15, 2023 Direct
Pear Therapeutics, Inc. Chief Medical Officer Common Stock 106K Jan 14, 2023 Direct
Pear Therapeutics, Inc. Chief Medical Officer Class A Common Stock 94.3K Jan 20, 2023 Direct
Pear Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 73.5K Feb 16, 2022 Direct

Insider Reports Filed by Yuri Maricich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEARQ Pear Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Medical Officer
PEARQ Pear Therapeutics, Inc. Jan 20, 2023 1 -$13.7K 4 Jan 24, 2023 Chief Medical Officer
PEARQ Pear Therapeutics, Inc. Jan 14, 2023 2 $0 4 Jan 18, 2023 Chief Medical Officer
PEARQ Pear Therapeutics, Inc. Feb 16, 2022 2 $0 4 Feb 18, 2022 Chief Medical Officer
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 8 $0 4 Dec 7, 2021 Chief Medical Officer
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Chief Medical Officer